Enocitabine
- CAS No.
- 55726-47-1
- Chemical Name:
- Enocitabine
- Synonyms
- BH-AC;CS-1807;SUNRABIN;NSC-239336;ENOCITABINE;Enocitabine API;BEHENOYLCYTOSINE ARABINOSIDE;N4-Behenoylcytosine arabinoside;n(sup4)-behenoylcytosinearabinoside;ENOCITABINE 98.5+% ANTINEOPLASTIC DRUGS
- CBNumber:
- CB3266605
- Molecular Formula:
- C31H55N3O6
- Molecular Weight:
- 565.78
- MOL File:
- 55726-47-1.mol
- Modify Date:
- 2024/3/16 17:22:18
| Melting point | 141-142°C |
|---|---|
| alpha | D +70° (c = 1 in THF, 22°) |
| Boiling point | 630.87°C (rough estimate) |
| Density | 1.0967 (rough estimate) |
| refractive index | 1.7800 (estimate) |
| storage temp. | Keep in dark place,Sealed in dry,Store in freezer, under -20°C |
| solubility | DMSO (Slightly, Heated), Methanol (Slightly, Heated), THF (Slightly, Heated, Soncited) |
| pka | 10.14±0.20(Predicted) |
| form | Solid |
| color | White to Off-White |
| CAS DataBase Reference | 55726-47-1(CAS DataBase Reference) |
Enocitabine Chemical Properties,Uses,Production
Description
Enocitabine (NSC-239336, BHAC) is an antileukemic agent closely related to cytarabine. It appears more resistant to deamination than cytarabine, thus allowing greater in vivo phosphorylation into an active cytotoxic metabolite. Enocitabine is lipophilic, but the drug does not enter the cerebrospinal fluid and is concentrated in the bone marrow and red blood cells. It can be administered orally and appears to be more effective than the parent compound in preclinical models.
Chemical Properties
Crystalline Solid
Enocitabine Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 98)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
| CONIER CHEM AND PHARMA LIMITED | +8618523575427 | China | 49392 | 58 | Inquiry |
| career henan chemical co | +86-0371-86658258 +8613203830695 | China | 29821 | 58 | Inquiry |
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | United States | 19892 | 58 | Inquiry |
| Dayang Chem (Hangzhou) Co.,Ltd. | 571-88938639 +8617705817739 | China | 52861 | 58 | Inquiry |
| NewCan Biotech Limited | +86-0571-86912261 +8613735419629 | China | 9980 | 58 | Inquiry |
| InvivoChem | +1-708-310-1919 +1-13798911105 | United States | 6393 | 58 | Inquiry |
| GIHI CHEMICALS CO.,LIMITED | +8618058761490 | China | 50003 | 58 | Inquiry |
| Henan Fengda Chemical Co., Ltd | +86-371-86557731 +86-13613820652 | China | 20291 | 58 | Inquiry |
| Zhengzhou Chemprize Biotech Co., Ltd. | +86-86-0371-56768238 +8615981919713 | China | 297 | 58 | Inquiry |
55726-47-1(Enocitabine)Related Search:
chevron_left
1of4
chevron_right
N-(1-BETA-D-ARABINOFURANOSYL-1,2-DIHYDRO-2-OXO-4-PYRIMIDINYL)DOCOSANAMIDE
NSC-239336
SUNRABIN
BEHENOYLCYTOSINE ARABINOSIDE
BH-AC
ENOCITABINE
n-(1-beta-d-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-docosanamid
n(sup4)-behenoyl-1-beta-d-arabinofuranosylcytosine
n(sup4)-behenoylcytosinearabinoside
N-[1-[(2R,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-pyrimidin-4-yl]docosanamide
1-β-D-Arabinofuranosyl-4-(1-oxodocosyl)amino-1,2-dihydropyrimidin-2-one
Enocitabine API
N-(1-B-D-Arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)docosanamide, Behenoylcytosine Arabinoside, BH-AC, NSC-239336, Sunrabin
Docosanamide, N-(1-β-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-
N4-Behenoyl-1-β-D-arabinofuranosylcytosine
N4-Behenoylcytosine arabinoside
N-[1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide
ENOCITABINE 98.5+% ANTINEOPLASTIC DRUGS
N-[1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide Enocitabine
CS-1807
1-benzimidazolyl-(5-bromo-2-furanyl)methanone
N(4)-behenoyl-1-beta-arabinofuranosylcytosine
N-(1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)docosanamide
Inhibitor,CMV,Enocitabine,inhibit,DNA/RNA Synthesis,Sunrabin,Cytomegalovirus,AML,acute myelogenous leukaemia,Nucleoside Antimetabolite/Analog
N-{1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}docosanamide
55726-47-1
C31H55N3O6
Intermediates & Fine Chemicals
Pharmaceuticals